Your search returned 719 results.

Results
	301.	Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib. [electronic resource] by Kauffmann-Guerrero, Diego Kahnert, Kathrin Kumbrink, Jörg Syunyaeva, Zulfiya Tufman, Amanda Huber, Rudolf M Producer: 20190625 In: Clinical lung cancer vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	302.	Optimizing the sequence of anti-EGFR-targeted therapy in EGFR-mutant lung cancer. [electronic resource] by Meador, Catherine B Jin, Hailing de Stanchina, Elisa Nebhan, Caroline A Pirazzoli, Valentina Wang, Lu Lu, Pengcheng Vuong, Huy Hutchinson, Katherine E Jia, Peilin Chen, Xi Eisenberg, Rosana Ladanyi, Marc Politi, Katerina Zhao, Zhongming Lovly, Christine M Cross, Darren A E Pao, William Producer: 20151103 In: Molecular cancer therapeutics vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	303.	The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) applied to pivotal phase III randomized-controlled trials of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating epidermal growth factor receptor mutations. [electronic resource] by Giuliani, Jacopo Remo, Andrea Bonetti, Andrea Producer: 20170322 In: Expert review of pharmacoeconomics & outcomes research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	304.	Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer. [electronic resource] by Jones, M R Lim, H Shen, Y Pleasance, E Ch'ng, C Reisle, C Leelakumari, S Zhao, C Yip, S Ho, J Zhong, E Ng, T Ionescu, D Schaeffer, D F Mungall, A J Mungall, K L Zhao, Y Moore, R A Ma, Y Chia, S Ho, C Renouf, D J Gelmon, K Jones, S J M Marra, M A Laskin, J Producer: 20180502 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	305.	Tyrosine Kinase Inhibitor Gold Nanoconjugates for the Treatment of Non-Small Cell Lung Cancer. [electronic resource] by Cryer, Alexander M Chan, Cheuk Eftychidou, Anastasia Maksoudian, Christy Mahesh, Mohan Tetley, Teresa D Spivey, Alan C Thorley, Andrew J Producer: 20190826 In: ACS applied materials & interfaces vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	306.	Afatinib for the treatment of advanced non-small-cell lung cancer. [electronic resource] by Genova, Carlo Rijavec, Erika Barletta, Giulia Burrafato, Giovanni Biello, Federica Dal Bello, Maria Giovanna Coco, Simona Truini, Anna Alama, Angela Boccardo, Francesco Grossi, Francesco Producer: 20141106 In: Expert opinion on pharmacotherapy vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	307.	Long progression-free survival with afatinib in a patient with EGFR-unknown lung adenocarcinoma after erlotinib failure: a case report. [electronic resource] by Vitale, Maria Giuseppa Scagliarini, Sarah Riccardi, Ferdinando Barbato, Carmela Otero, Manuela Mocerino, Carmela Ambrosio, Francesca Cartenì, Giacomo Producer: 20150720 In: Tumori vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	308.	Clinical Pharmacokinetics and Pharmacodynamics of Afatinib. [electronic resource] by Wind, Sven Schnell, David Ebner, Thomas Freiwald, Matthias Stopfer, Peter Producer: 20171116 In: Clinical pharmacokinetics vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	309.	Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib. [electronic resource] by Yamaoka, Toshimitsu Ohba, Motoi Matsunaga, Yuki Tsurutani, Junji Ohmori, Tohru Producer: 20200612 In: Journal of visualized experiments : JoVE no. 148 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	310.	Intracranial Responses to Afatinib at Different Doses in Patients With EGFR-mutated Non-small-cell Lung Carcinoma and Brain Metastases. [electronic resource] by Wei, Yu-Feng Lim, Chor-Kuan Tsai, Mao-Song Huang, Ming-Shyan Chen, Kuan-Yu Producer: 20200403 In: Clinical lung cancer vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	311.	The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma. [electronic resource] by Truini, Anna Starrett, Jacqueline H Stewart, Tyler Ashtekar, Kumar Walther, Zenta Wurtz, Anna Lu, David Park, Jin H DeVeaux, Michelle Song, Xiaoling Gettinger, Scott Zelterman, Daniel Lemmon, Mark A Goldberg, Sarah B Politi, Katerina Producer: 20200908 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	312.	Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with Cetuximab. [electronic resource] by Oashi, Ayano Yasuda, Hiroyuki Kobayashi, Keigo Tani, Tetsuo Hamamoto, Junko Masuzawa, Keita Manabe, Tadashi Terai, Hideki Ikemura, Shinnosuke Kawada, Ichiro Naoki, Katsuhiko Soejima, Kenzo Producer: 20200617 In: Molecular cancer therapeutics vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	313.	Afatinib restrains K-RAS-driven lung tumorigenesis. [electronic resource] by Moll, Herwig P Pranz, Klemens Musteanu, Monica Grabner, Beatrice Hruschka, Natascha Mohrherr, Julian Aigner, Petra Stiedl, Patricia Brcic, Luka Laszlo, Viktoria Schramek, Daniel Moriggl, Richard Eferl, Robert Moldvay, Judit Dezso, Katalin Lopez-Casas, Pedro P Stoiber, Dagmar Hidalgo, Manuel Penninger, Josef Sibilia, Maria Győrffy, Balázs Barbacid, Mariano Dome, Balázs Popper, Helmut Casanova, Emilio Producer: 20190930 In: Science translational medicine vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	314.	Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma. [electronic resource] by Reardon, David A Nabors, Louis B Mason, Warren P Perry, James R Shapiro, William Kavan, Petr Mathieu, David Phuphanich, Surasak Cseh, Agnieszka Fu, Yali Cong, Julie Wind, Sven Eisenstat, David D Producer: 20160318 In: Neuro-oncology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	315.	A neoadjuvant, randomized, open-label phase II trial of afatinib versus trastuzumab versus lapatinib in patients with locally advanced HER2-positive breast cancer. [electronic resource] by Rimawi, Mothaffar F Aleixo, Sabina B Rozas, Ashley Alarcon Nunes de Matos Neto, João Caleffi, Maira Figueira, Alicardo Cesar Souza, Sulene Cunha Reiriz, Andre B Gutierrez, Carolina Arantes, Heloisa Uttenreuther-Fischer, Martina M Solca, Flavio Osborne, C Kent Producer: 20151202 In: Clinical breast cancer vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	316.	Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitors. [electronic resource] by Tu, Yuanbiao OuYang, Yiqiang Xu, Shan Zhu, Yan Li, Gen Sun, Chao Zheng, Pengwu Zhu, Wufu Producer: 20161108 In: Bioorganic & medicinal chemistry vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	317.	Cardiovascular safety of novel non-small cell lung cancer oncotherapy in a patient treated with novel generations of tyrosine kinase inhibitors. [electronic resource] by Szymański, Filip M Płatek, Anna E Dziadziuszko, Rafał Łęgosz, Paweł Palczewski, Piotr Producer: 20181126 In: Kardiologia polska vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	318.	Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers. [electronic resource] by Cheng, Chun-Chia Lin, Hsin-Chi Tsai, Kaun-Jer Chiang, Ya-Wen Lim, Ken-Hong Chen, Caleb Gon-Shen Su, Ying-Wen Peng, Cheng-Liang Ho, Ai-Sheng Huang, Ling Chang, Yu-Cheng Lin, Huan-Chau Chang, Jungshan Chang, Yi-Fang Producer: 20190506 In: Molecular carcinogenesis vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	319.	TAS6417/CLN-081 Is a Pan-Mutation-Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant [electronic resource] by Udagawa, Hibiki Hasako, Shinichi Ohashi, Akihiro Fujioka, Rumi Hakozaki, Yumi Shibuya, Mikiko Abe, Naomi Komori, Toshiharu Haruma, Tomonori Terasaka, Miki Fujita, Ryoto Hashimoto, Akihiro Funabashi, Kaoru Yasuda, Hiroyuki Miyadera, Kazutaka Goto, Koichi Costa, Daniel B Kobayashi, Susumu S Producer: 20200728 In: Molecular cancer research : MCR vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	320.	Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy. [electronic resource] by Tokudome, Nahomi Koh, Yasuhiro Akamatsu, Hiroaki Fujimoto, Daichi Okamoto, Isamu Nakagawa, Kazuhiko Hida, Toyoaki Imamura, Fumio Morita, Satoshi Yamamoto, Nobuyuki Producer: 20201026 In: BMC cancer vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 719 results.